The clinical decision support systems (CDSS) market size is estimated to be USD 1,345.5 million in 2022 and is expected to witness a CAGR of 10.7% during the forecast period 2023-2033. The rising use of EHRs with CDSS functionality, adoption of government policies and programs to encourage the use of HCIT solutions, and an increase in stakeholder alliances and cooperation are factors contributing to the market growth. However, compatibility problems and issues with cloud-based CDSS data security is expected to hinder the growth.

Segmentation

By Application

Based on application, the market is bifurcated into conventional CDSS, and advanced CDSS. In 2022, the advanced CDSS segment held the highest market share owing to increasing allergy-related medication burden.

By Component

On the basis of component, the market is segregated into hardware, software, and services. In 2022, the services segment held the highest market share due to frequent use of software and level of knowledge updates.

By Product

Based on product, the market is bifurcated into standalone CDSS, integrated CDSS, integrated CDSS with CPOE & EHR, and integrated EHR with CDSS. In 2022, the standalone CDSS segment held the highest market share due to its minimal price & accessibility, and it is extensively used.

By Delivery Mode

Based on delivery mode, the market is segregated into cloud based, on premise, and web-based. In 2022, the cloud-based segment held the highest market share due to major advancements in information technology having practical benefits in healthcare, and overall reliability and affordability.

Regional Markets

In 2022, North America region accounted for the highest revenue in the clinical decision support systems (CDSS) market and is expected to maintain its dominance during the forecast period. This is attributed to the progress in technology, increasing need in the medical industry for healthcare IT solutions, and rising significance of delivering high-quality healthcare services. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the growing number of elderly people, increased financial support for the healthcare industry in nations including Australia, China, India, and Japan, growing R&D spending by important economies’ governments, and escalating use of digital technologies in the medical industry.

Competitor Insights

Some of the key players operating in the clinical decision support systems (CDSS) market are Allscripts Healthcare LLC (US), athenahealth (US), Cerner Corporation (US), Change Healthcare (US), EBSCO Health (US), Elsevier B.V. (UK), Epic Systems (US), GE Healthcare (US), IBM Watson Health (US), MEDITECH (US), NextGen Healthcare (US), Philips Healthcare (Netherlands), Siemens Healthineers (US), Wolters Kluwer N.V. (Netherlands), and Zynx Health (US).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including application, component, product, and delivery mode from 2023 to 2033.

Report Scope:

Segmentation: Clinical Decision Support Systems (CDSS) Market Report 2022 – 2033

Application (Revenue, USD Million), 2022 – 2033

• Conventional CDSS
• Advanced CDSS

Component (Revenue, USD Million), 2022 – 2033

• Hardware
• Software
• Services

By Product (Revenue, USD Million), 2022 – 2033

• Standalone CDSS
• Integrated CDSS
• Integrated CDSS with CPOE & EHR
• Integrated EHR with CDSS

By Delivery Mode (Revenue, USD Million), 2022 – 2033

• Cloud based
• On Premise
• Web-based

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA